Skip to main
CVRX

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 0%
Sell 17%
Strong Sell 0%

Bulls say

CVRx Inc has demonstrated significant growth in its operational capacity, achieving a total of 240 active implanting centers at the end of the quarter, which reflects an increase of 13 centers sequentially. Although the company's total operating expenses rose approximately 8% year-over-year to $25.8 million, this increase is mainly attributed to a notable 11% year-over-year hike in selling, general, and administrative costs to $23.4 million. The ongoing expansion of implanting centers, coupled with the innovative Barostim platform technology, positions CVRx favorably in the growing market for minimally invasive neuromodulation solutions for cardiovascular diseases.

Bears say

CVRx Inc has revised its FY25 revenue guidance downward to a range of $55.0 - $57.0 million, indicating a limited growth forecast of approximately 7-11% year-over-year. Additionally, the company has reduced its 2026 revenue estimate from $74.1 million to $67.6 million, suggesting a slower-than-expected ramp in U.S. market performance. The gross margin remained flat at 84% in 2Q25, which raises concerns about the company’s ability to enhance profitability amidst declining revenue projections.

CVRx (CVRX) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 6 analysts, CVRx (CVRX) has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.